Data as of Oct 21
 +0.01 / +0.84%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Vical, Inc. researches and develops biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. The company's core technology involves the insertion of DNA into plasmids designed to deliver the desired genes into cells in the body. Its development programs include Infectious disease vaccines for use in high-risk populations and Infectious disease vaccines for general pediatric, adolescent and adult populations. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.

Contact Information

Vical, Inc.
10390 Pacific Center Court
San Diego California 92121-4340
P:(858) 646-1100
Investor Relations:
(858) 646-1127



Other institutional25.79%
Individual stakeholders21.00%
Mutual fund holders13.67%

Top Executives

Vijay B. SamantPresident, Chief Executive Officer & Director
Larry Russell SmithVice President-Vaccine Research
Igor P. BilinskySenior Vice President-Corporate Development
Mammen P. MammenVice President-Clinical Vaccines
Anthony Alan RamosChief Accounting Officer & Vice President-Finance

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.